On Sunday, March 22, “60 Minutes” featured a new segment by Emmy Award-winning correspondent and HWS Trustee Bill Whitaker ’73, L.H.D. ’97, examining the aggressive approach researchers are taking to find potential vaccine and treatment options for the Novel Coronavirus (COVID-19).
“With the Novel Coronavirus extending its shadow of illness and death globally, the U.S. Food and Drug Administration and the National Institutes of Health are now slashing red tape to expedite research so promising vaccines and therapies can be developed as quickly as possible,” Whitaker reports. “To date there is no proven medical way to stop this coronavirus — no treatment, no vaccine. The best defense has been tried-and-true public health measures: social distancing and hand washing. But the rapid spread of the deadly virus prompted medical researchers the world over to go on offense.”
In the segment, Whitaker talks with researchers about experimental treatments and what it takes to swiftly develop a vaccine.
As a “60 Minutes” correspondent, Whitaker has reported stories from across the world — from the Syrian refugee crisis to the issue of race and policing in America. In 2017 and 2018, he and his colleagues produced two investigative reports on how politics and drug industry lobbying helped fuel the country’s opioid epidemic. Among the eight awards the reporting won are the DuPont-Columbia University award, the Peabody, an Emmy and an RTDNA Murrow award.